S-1/A: QDM International Files S-1/A for Public Offering Amid Strong Growth

QDM International Inc., a Hong Kong-based insurance brokerage, filed an S-1/A for a public offering of 1.25 million common shares, reporting significant revenue and net income growth for Q2 2025 and FY2025.

Summary

• QDM International Inc. (QDM) is a Florida holding company that conducts its insurance brokerage business primarily in Hong Kong through its indirectly wholly-owned subsidiary, YeeTah.
• The company is undertaking a firm commitment public offering of 1,250,000 shares of common stock, with an over-allotment option for an additional 187,500 shares.
• QDM has applied to list its common stock on The Nasdaq Stock Market LLC (Nasdaq) under the symbol QDMI, currently trading on the OTCQB Venture Market.
• For the three months ended June 30, 2025, revenue increased by 272.8% to $3,594,997, and net income surged by 378.1% to $2,196,305 compared to the same period in 2024.
• For the fiscal year ended March 31, 2025, total revenue grew by 23.2% to $8,381,274, and net income increased by 208.3% to $4,823,338 compared to FY2024.
• The significant increase in net income for FY2025 was primarily driven by a 72.8% decrease in cost of sales, attributed to lower referral fees paid following a Hong Kong Insurance Authority circular.
• QDM's business model expanded in December 2023 to include referral partnerships with a trust company in Hong Kong for asset management services, generating $540,616 in revenue for FY2025.
• Huihe Zheng, the CEO, President, and Chairman, holds approximately 99.0% of the company's total voting power post-offering, making QDM a controlled company under Nasdaq rules, though it does not intend to rely on the exemptions.
• The company has identified material weaknesses in its internal control over financial reporting, including a lack of proper segregation of duties, formal documentation, and independent directors/audit committee, but is implementing remediation measures.
• Net proceeds from the offering, estimated at $4.4 million (or $5.2 million with over-allotment), are planned for expansion of service offerings (40%), marketing and branding (20%), new hires and training (10%), and working capital/general corporate purposes (30%).
• New investors in this offering will experience an immediate and substantial dilution of $2.95 per share, based on an assumed offering price of $4.50 per share.

Sentiment

Score: 7

Explanation: The company demonstrates strong financial growth in both quarterly and annual results, driven by strategic expansion and improved cost management. The public offering aims to fund further growth. However, significant concentration risks, internal control weaknesses, and the substantial influence of the CEO, coupled with geopolitical uncertainties related to Hong Kong and PRC regulations, temper the overall positive outlook.

Positives

• Revenue for the three months ended June 30, 2025, increased significantly by 272.8% to $3,594,997, driven by expanded insurance partner collaborations, increased policy sales, and higher commission rates.
• Net income for the three months ended June 30, 2025, saw a substantial increase of 378.1% to $2,196,305.
• Annual revenue for the fiscal year ended March 31, 2025, grew by 23.2% to $8,381,274, with net income increasing by 208.3% to $4,823,338.
• Gross profit margin increased by 48.8% for FY2025 due to a significant decrease in cost of sales, resulting from lower referral fee rates in compliance with regulatory directives.
• The company successfully expanded its business model in December 2023 by entering a collaborative partnership with a Hong Kong trust company for asset management referrals, diversifying revenue streams.
• Cash and cash equivalents increased to $12,409,685 as of June 30, 2025, from $8,557,305 as of March 31, 2025, indicating strong cash generation from operating activities.
• QDM maintains good relationships with 23 insurance companies in Hong Kong, offering approximately 582 insurance products, and has an experienced management team and a strong commitment to training.
• The company is actively recruiting technical representatives and plans to expand its distribution network through strategic partnerships in Hong Kong and mainland China, including wealth management companies, funds, trust companies, and overseas immigration agencies.
• Remediation efforts for internal control weaknesses are underway, including hiring a qualified CFO, engaging external consulting for SOX compliance, and appointing an independent director nominee.

Negatives

• The company faces significant concentration risk, with approximately 72.4% of total commissions for Q2 2025 and 68.1% for FY2025 attributed to a single insurance company, and over 80% from a limited number of partners.
• New investors will experience immediate and substantial dilution of $2.95 per share, as the offering price is significantly higher than the pro forma as adjusted net tangible book value per share.
• The company has identified material weaknesses in its internal control over financial reporting, including a lack of proper segregation of duties, formal documentation, and independent directors/audit committee, which could lead to misstatements.
• General and administrative expenses increased by 116.3% for FY2025 and 47.6% for Q2 2025, primarily due to hiring more employees, technical representatives, and increased professional fees.
• Other income decreased by 93.9% for FY2025, mainly due to a non-recurring gain from the disposition of subsidiaries in the prior year.
• The company's CEO, President, and Chairman, Mr. Huihe Zheng, holds approximately 99.0% of the voting power, raising concerns about potential misalignment of interests with other shareholders and his ability to prevent or cause a change of control.
• The market for the company's common stock is currently limited (OTCQB), and there is no assurance that an active public market will develop or be sustained on Nasdaq.
• The company has never paid cash dividends and does not anticipate doing so in the foreseeable future, intending to retain all earnings for business expansion.

Risks

• Dependence on a single or limited number of insurance company partners for a significant portion of revenue, posing concentration risks.
• Inability to attract and retain highly productive licensed technical representatives, which are crucial for sales.
• Potential material adverse effects on business, results of operations, or financial condition due to misconduct of technical representatives.
• Extensive regulations in Hong Kong for insurance brokerage and MPF intermediary businesses; failure to comply could result in fines, sanctions, or license revocation.
• Intense competition in the Hong Kong insurance intermediary industry from in-house sales forces, banks, and other brokerages, potentially leading to loss of customers.
• Commission revenue is subject to quarterly fluctuations due to business seasonality, timing of policy renewals, and the net effect of new and lost business, which are outside the company's control.
• Reliance on dividends and other distributions from the Hong Kong operating subsidiary for cash and financing requirements, with potential limitations or restrictions by the PRC government on cash/asset transfers.
• Political risks and economic instability in Hong Kong, and potential changes in PRC government policies, could adversely impact operations and financial results.
• Substantial uncertainties and restrictions with respect to the political and economic policies of the PRC government and PRC laws and regulations could significantly impact business in Hong Kong.
• The enactment of the Law of the PRC on Safeguarding National Security in the Hong Kong Special Administrative Region could impact the Hong Kong operating subsidiary.
• Risk of PRC government intervention or influence over operations at any time, potentially limiting the ability to offer securities to investors or causing securities to decline in value.
• Potential for new or modified PRC laws and regulations (e.g., cybersecurity, data privacy, anti-monopoly) to become applicable to the company, leading to increased compliance costs or penalties.
• Trading in securities may be prohibited under the Holding Foreign Companies Accountable Act (HFCA Act) if the PCAOB determines it cannot inspect or investigate the company's auditor for two consecutive years.
• Difficulty for shareholders to enforce U.S. judgments against the company or its officers/directors due to assets and personnel being primarily in Hong Kong/mainland China.
• The company's CEO, President, and Chairman, Mr. Huihe Zheng, has substantial influence (99.0% voting power) over the company, and his interests may not align with other shareholders.
• Considerable discretion in the use of net proceeds from the offering, which may be used in ways investors do not agree with or that do not improve profitability.
• Limited public trading market for common stock on OTCQB, with no assurance of an active market developing or being sustained on Nasdaq.
• The company's status as a 'penny stock' may subject it to additional sale and trading regulations, making it more difficult to sell shares.
• Future equity offerings could lead to additional dilution for existing shareholders.
• Sales of substantial amounts of common stock by existing shareholders after lock-up periods could adversely affect market prices.
• The company will incur increased costs and management time for compliance as a public company listed on Nasdaq, especially with Sarbanes-Oxley Act requirements.
• As a smaller reporting company, reduced disclosure requirements may make common stock less attractive to some investors.
• If securities or industry analysts do not publish research or publish negative reports, the stock price and trading volume could decline.

Future Outlook

The company intends to capitalize on the growth potential of Hong Kong's insurance industry, particularly the life insurance sector, by actively recruiting sales and marketing professionals, improving technical representative productivity through rigorous training, and leveraging its customer base for cross-selling. It also plans to expand its distribution network by building relationships with strategic partners in Hong Kong and mainland China, such as wealth management companies, funds, trust companies, and overseas immigration agencies, and to strengthen relationships with leading insurance companies to obtain favorable commission rates and exclusive product distribution rights.

Management Comments

• Management believes that providing superior customer service is the most important aspect of the business for brand building and product differentiation.
• Management believes the company's ability to offer concentrated products and services makes it an attractive distributor for insurance company partners and enables quality service to customers.
• Management believes YeeTah's strong in-house training program gives it a competitive edge over other professional insurance intermediaries and helps retain its sales force and improve sales.
• Management believes that the PRC's rapidly aging population, high national savings rate, sustained economic development, rising household income, strong government support, and enhanced risk protection awareness will drive faster growth in Hong Kong's life and medical insurance sector.
• Management believes the company is in full compliance with the Personal Data (Privacy) Ordinance of Hong Kong.
• Management believes that the dispositions of current legal proceedings and claims, individually or in the aggregate, are not expected to have a material adverse effect on the company's financial condition.

Industry Context

The Hong Kong insurance market is highly developed, with a high per capita insurance premium and a 20.0% penetration rate in 2022, significantly higher than the U.S. (11.6%) and mainland China (3.9%). The market is forecasted to grow at a CAGR of 6.6% from 2024 to 2032, driven by increasing disposable income, a rising geriatric population, growing chronic diseases, and strong demand for health and risk protection from Chinese visitors. However, challenges include limited penetration of online insurance and complex industry regulations (e.g., IFRS 17) that may restrict emerging players. The resumption of cross-border travel and regional integration with the Greater Bay Area is expected to fuel sales of insurance policies to mainland Chinese visitors, who are attracted to Hong Kong's tax-free life and health insurance policies.

Comparison to Industry Standards

• Hong Kong's insurance penetration rate of 20.0% in 2022 is significantly higher than global benchmarks, including 11.6% in the United States, 11.1% in South Korea, and 10.5% in the United Kingdom, indicating a mature and robust local market for QDM's operations.
• The forecasted CAGR of 6.6% for the Hong Kong insurance industry from 2024 to 2032 suggests a healthy growth environment, which QDM aims to leverage through its focus on the life insurance sector.
• QDM's strategy to focus on life insurance products aligns with the industry trend of strong demand for health and risk protection, particularly from mainland Chinese visitors, who seek Hong Kong's tax-free and comprehensive policies due to limited development in China.
• The company's reliance on a limited number of insurance partners (e.g., 72.4% of Q2 2025 commissions from one company) indicates a higher concentration risk compared to a more diversified industry standard for insurance brokerages.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not involved in any material legal proceedings, nor is it aware of any threatened legal proceedings in which any director or officer or their affiliates is a party adverse to the company or has a material interest adverse to it.

Related Party Transactions

• Huihe Zheng, the CEO, President, and Chairman, advanced $129,056 to the company during FY2025 (and $244,313 in FY2024) to support operations.
• The company repaid $812,277 to Huihe Zheng during FY2025.
• On October 9, 2024, the company issued 6,000,000 Series B Preferred Stock to Huihe Zheng at $0.10 per share, in exchange for the cancellation of $600,000 of debt owed to him.
• A Shareholder Agreement was entered into with Huihe Zheng on October 1, 2025, imposing transfer restrictions on his Series B shares, waiving his co-sale rights, and granting the company a repurchase right for these shares at $0.001 per share upon certain transactions.

Stakeholder Impact

• Shareholders: New investors will face immediate and substantial dilution. Existing shareholders, particularly Mr. Zheng, will retain significant voting control. The public offering aims to provide capital for growth, potentially benefiting all shareholders in the long term, but the stock's liquidity and price stability are uncertain.
• Employees/Technical Representatives: The company plans to use offering proceeds for new hires and training, which could benefit employees and technical representatives through growth opportunities and improved skills. Misconduct by technical representatives remains a risk to the company's reputation and financial health.
• Customers: The company's growth strategies focus on expanding service offerings and distribution networks, aiming to provide a broader range of products and premium services, which could benefit customers. However, reliance on a few insurance partners could limit product diversity if relationships deteriorate.
• Insurance Company Partners: Strengthening relationships with leading insurance companies is a key strategy, potentially leading to more favorable commission rates and exclusive product rights, benefiting these partners.
• Regulatory Bodies: The company is actively addressing internal control weaknesses and complying with Hong Kong and U.S. regulations, including those related to data privacy and competition, which is crucial for maintaining operational legitimacy and avoiding penalties.

Next Steps

• Complete the public offering of common stock and list on Nasdaq.
• Implement the remediation plan for identified material weaknesses in internal control over financial reporting, including hiring qualified accounting personnel, organizing training, formulating U.S. GAAP policies, and establishing an audit committee.
• Hold an annual meeting of shareholders to elect directors within the next twelve months.
• Continue to expand service offerings, marketing and branding efforts, and hire new management, sales, and customer service personnel using the proceeds from the offering.
• Further participate in the growing life-insurance sector in Hong Kong and improve the productivity of individual technical representatives.
• Expand the distribution network by building relationships with strategic partners in Hong Kong and mainland China (e.g., wealth management companies, funds, trust companies, overseas immigration agencies).
• Strengthen relationships with leading insurance companies to obtain favorable commission rates and exclusive rights to distribute high-margin products.

Key Dates

Recommendation

QDM International Inc. demonstrates impressive recent financial growth, particularly in revenue and net income, driven by strategic business expansion into referral services and improved cost management. The planned Nasdaq listing and capital raise are positive steps for market visibility and funding future growth initiatives. However, the significant concentration of revenue from a limited number of insurance partners, the substantial dilution for new investors, and identified material weaknesses in internal controls present notable risks. Furthermore, the high voting control by the CEO and the inherent geopolitical uncertainties of operating in Hong Kong under potential PRC government influence introduce additional layers of risk. While the growth trajectory is compelling, these risks warrant a cautious approach. A 'hold' recommendation allows investors to observe the successful execution of the Nasdaq listing, the effectiveness of internal control remediation, and any diversification efforts to mitigate concentration risks, before committing further capital.

Keywords

Insurance Brokerage, Hong Kong, SEC Filing, Public Offering, Financial Performance, QDM International, YeeTah, Life Insurance, General Insurance, MPF Services, Referral Business, Nasdaq Listing, Controlled Company, Internal Controls, Risk Factors, Huihe Zheng, Share Dilution, Capital Raise, Corporate Governance, PRC Regulations, HFCA Act